CeriBell, Inc. (CBLL)

CeriBell, Inc. is a medical technology company headquartered in Sunnyvale, California. It completed its initial public offering on the Nasdaq in 2024.

Ceribell has developed a point-of-care electroencephalography (EEG) system designed for rapid use in acute care settings such as intensive care units and emergency departments. The system pairs a quick-to-apply headband and portable recorder with cloud-connected software and artificial intelligence algorithms that continuously monitor brain activity and flag possible seizures, including non-convulsive seizures that are difficult to detect without EEG. The goal is to help clinicians diagnose and treat seizures faster in critically ill patients. The company sells its products to hospitals, combining disposable headbands with recurring software subscriptions.